Title |
The use of botulinum toxin type A in the treatment of HTLV-1-associated overactive bladder refractory to conventional therapy
|
---|---|
Published in |
Revista da Sociedade Brasileira de Medicina Tropical, August 2014
|
DOI | 10.1590/0037-8682-0029-2014 |
Pubmed ID | |
Authors |
José Abraão Carneiro, Valéria Gusmão Bittencourt, Cassius de Oliveira, Rosana Andrade, Edgar Marcelino de Carvalho |
Abstract |
Urinary symptoms occur in 19% of human T-cell lymphotropic virus type 1 (HTLV-1)-infected patients who do not fulfill criteria for HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and in almost 100% of HAM/TSP patients. Few studies have evaluated therapies for overactive bladder (OAB) caused by HTLV-1 infection. This case report describes the effect of onabotulinum toxin A on the urinary manifestations of three patients with HAM/TSP and OAB symptoms. The patients were intravesically administered 200 units of Botox®. Their incontinence episodes improved, and their OAB symptoms scores (OABSS) reduced significantly. These data indicate that Botox® should be a treatment option for OAB associated with HTLV-1 infection. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Brazil | 2 | 6% |
Spain | 1 | 3% |
Unknown | 28 | 90% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Postgraduate | 4 | 13% |
Student > Bachelor | 4 | 13% |
Student > Master | 4 | 13% |
Other | 3 | 10% |
Student > Ph. D. Student | 3 | 10% |
Other | 7 | 23% |
Unknown | 6 | 19% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 17 | 55% |
Agricultural and Biological Sciences | 2 | 6% |
Biochemistry, Genetics and Molecular Biology | 1 | 3% |
Computer Science | 1 | 3% |
Nursing and Health Professions | 1 | 3% |
Other | 2 | 6% |
Unknown | 7 | 23% |